Skip to main navigation
Vaxcyte
  • Mission
  • Pipeline
  • Approach
  • About Us
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financials & Filings
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • IR Contact
      • Tax Disclosures
  • Careers & Culture
    • Careers
    • Culture
    • Job Listings
Select Page
  • RSS Feeds
  • Email Alerts
  • IR Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Apr 23, 2026
Document Date
Jun 15, 2026
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Vaxcyte, Inc.
Issuer
VAXCYTE, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Vaxcyte

ABOUT US

  • Corporate Profile
  • Management Team
  • Board of Directors
  • Scientific Advisory Board

PIPELINE

  • High-Fidelity Vaccines Engineered to Go the Distance
  • The Rising Consequences of Bacterial Infections
  • Vaccine Candidates Engineered to Overtake Convention
  • Posters & Publications

INVESTORS & MEDIA

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Investor Resources
© 2026 Vaxcyte. All rights reserved.
Privacy Policy
Privacy Policy
© 2026 Vaxcyte.   All rights reserved.